Pharmacological treatment of acute coronary syndromes
General Material Designation
[Book]
First Statement of Responsibility
Pablo Avanzas, Peter Clemmensen, editors
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
London :
Name of Publisher, Distributor, etc.
Springer,
Date of Publication, Distribution, etc.
2013
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (260 pages)
SERIES
Series Title
Current Cardiovascular Therapy
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index
CONTENTS NOTE
Text of Note
Foreword -- Preface -- Anti-ischemic Therapy -- Antiaggregant Therapy: New potent P2Y12 inhibitors -- Anticoagulation Therapy: Heparins and Factor Xa inhibitors -- Secondary prevention in ACS The role of novel oral anticoagulants -- American vs European guidelines -- Critical appraisal -- Triple therapy: Risky but sometimes necessary -- Management of bleeding complications
0
SUMMARY OR ABSTRACT
Text of Note
Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series, and this particular title within the series, is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action, the possible adverse effects, and the management of patients prescribed these drugs
OTHER EDITION IN ANOTHER MEDIUM
Title
Pharmacological Treatment of Acute Coronary Syndromes.